Most cited papers from Xigen (Switzerland)
What are the most cited papers from Xigen (Switzerland)?
The most cited paper from Xigen (Switzerland) is "Cell-permeable peptides induce dose- and length-dependent cytotoxic effects" (Alessandra Kupper Cardozo, Valérie Büchillier, Marc N. Mathieu et al., 2007), with 124 citations. Next come "Synaptic Localization and Activity of ADAM10 Regulate Excitatory Synapses through N-Cadherin Cleavage" (121) and "The nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death" (98).
Showing 14 of 14 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Cell-permeable peptides induce dose- and length-dependent cytotoxic effects Alessandra Kupper Cardozo, Valérie Büchillier, Marc N. Mathieu et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes | 30 Jun 2007 | 124 |
| 2 | Synaptic Localization and Activity of ADAM10 Regulate Excitatory Synapses through N-Cadherin Cleavage Matteo Malinverno, Mario Carta, Roberta Epis et al. · Journal of Neuroscience | Dec 2010 | 121 |
| 3 | The nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death Lili Li, Vanessa Ginet, Xiaonan Liu et al. · Journal of Neuroscience | 8 May 2013 | 98 |
| 4 | JNK inhibition and inflammation after cerebral ischemia Corinne Benakis, Christophe Bonny, Lorenz Hirt · Brain Behavior and Immunity | 12 Nov 2009 | 74 |
| 5 | The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator Karine Wiegler, Christophe Bonny, Didier Coquoz et al. · Cerebrovascular Diseases | 2008 | 53 |
| 6 | Searching for new animal models of Alzheimer′s disease Roberta Epis, Fabrizio Gardoni, Elena Marcello et al. · European Journal of Pharmacology | 16 Oct 2009 | 49 |
| 7 | Novel Strategy for Treatment of Viral Central Nervous System Infection by Using a Cell-Permeating Inhibitor of c-Jun N-Terminal Kinase John David Beckham, Robin J Goody, Penny Clarke et al. · Journal of Virology | 3 May 2007 | 43 |
| 8 | c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage Delphine Michel-Monigadon, Christophe Bonny, Lorenz Hirt · Cerebrovascular Diseases | 2010 | 39 |
| 9 | The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats J-R. Liu, Yi Zhao, Andreas Patzer et al. · Neuropathology and Applied Neurobiology | 22 Oct 2009 | 35 |
| 10 | Comparison between a linear ion trap and a triple quadruple MS in the sensitive detection of large peptides at femtomole amounts on column Bilgin Vatansever, Sabine L. Lahrichi, Aly Thiocone et al. · Journal of Separation Science | 29 Jun 2010 | 26 |
| 11 | JNK Contributes to Hif-1α Regulation in Hypoxic Neurons Xanthi Antoniou, Alessandra Sclip, Cristina Ploia et al. · Molecules | 30 Dec 2009 | 19 |
| 12 | Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion Corinne Benakis, Anne Vaslin, Christian Pasquali et al. · Journal of Neuroinflammation | 25 Apr 2012 | 11 |
| 13 | 341 NEUROPATHIC PAIN AND SPINAL GLIA: CHARACTERIZATION OF C‐JUN N‐TERMINAL KINASE (JNK) ACTIVATION IN ASTROCYTE CULTURES Ahmed Beggah, Annabelle Parent, Marie Pertin et al. · European Journal of Pain | 10 May 2007 | 0 |
| 14 | Alterations of level of consciousness related to stroke Marc D. Reichhart · Cambridge University Press eBooks | 18 Jan 2007 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.